Hatim Husain (@hatimhusainmd) 's Twitter Profile
Hatim Husain

@hatimhusainmd

Medical oncologist. Interested in translational studies and new drug development.

ID: 906536754890641409

calendar_today09-09-2017 15:16:19

138 Tweet

477 Followers

170 Following

Gonzalo Recondo (@grecondomd) 's Twitter Profile Photo

Day 2 of #LATAMoncoSummit dedicated to the care of patients with EGFR exon 20 insertion mutations focusing on current strategies to detect these alterations when NGS is not available w W. William Vladmir C. Cordeiro de Lima, MD, PhD Jorge Alatorre Alexander Hatim Husain #LOS2023

Day 2 of #LATAMoncoSummit dedicated to the care of patients with EGFR exon 20 insertion mutations focusing on current strategies to detect these alterations when NGS is not available w W. William <a href="/ClaudioVladmir/">Vladmir C. Cordeiro de Lima, MD, PhD</a> <a href="/JorgeAlatorreA1/">Jorge Alatorre Alexander</a> <a href="/HatimHusainMD/">Hatim Husain</a> #LOS2023
MOASC (@moasc_office) 's Twitter Profile Photo

Don't forget to join us for our monthly Lung Cancer Series Webinar on Sept 27th at 6pm! Register here: bit.ly/3ZAswM3. Come learn about neoadjuvant and adjuvant therapy with our experts Hatim Husain Patrick Forde and Dr. Joshua Boys. UC San Diego Health Moores Cancer Center Johns Hopkins Kimmel Cancer Center

Don't forget to join us for our monthly Lung Cancer Series Webinar on Sept 27th at 6pm! Register here: bit.ly/3ZAswM3. Come learn about neoadjuvant and adjuvant therapy with our experts <a href="/HatimHusainMD/">Hatim Husain</a> <a href="/FordePatrick/">Patrick Forde</a> and Dr. Joshua Boys.

<a href="/UCSDCancer/">UC San Diego Health Moores Cancer Center</a> <a href="/hopkinskimmel/">Johns Hopkins Kimmel Cancer Center</a>
ScienceLink (@sciencelinkonco) 's Twitter Profile Photo

#ScienceLink #OncoCast Dra. Maritza Ramos (Maritza Ramos MD) y Dr. Hatim Husain (Hatim Husain) Osimertinib redujo el riesgo de muerte en un 51% en comparación con placebo en la población del análisis primario

#ScienceLink #OncoCast
Dra. Maritza Ramos (<a href="/maritza_rramos/">Maritza Ramos MD</a>) y 
Dr. Hatim Husain (<a href="/HatimHusainMD/">Hatim Husain</a>)
Osimertinib redujo el riesgo de muerte en un 51% en comparación con placebo en la población del análisis primario
MOASC (@moasc_office) 's Twitter Profile Photo

Our #LungCancer Webinar Series continues this month with our #radonc colleagues Chien Pong (Peter) Chen, MD, @scrippshealth, Ajay Sandhu, MD, @ucsdhealth and moderator Hatim Husain. Listen in as they discuss their preferred treatment for stage 3 disease youtu.be/MI7wKWvLh34

Our #LungCancer Webinar Series continues this month with our #radonc colleagues Chien Pong (Peter) Chen, MD, @scrippshealth, Ajay Sandhu, MD, @ucsdhealth and moderator <a href="/HatimHusainMD/">Hatim Husain</a>. Listen in as they discuss their preferred treatment for stage 3 disease youtu.be/MI7wKWvLh34
MOASC (@moasc_office) 's Twitter Profile Photo

Join is THIS Wed, Nov 29th at 6pm for another episode of our #LungCancer Webinar Series! Learn more about antibody drug conjugates from Dr. Aaron Lisberg . and Aaron Mansfield Mayo Clinic, moderated by Hatim Husain UC San Diego Health Moores Cancer Center. Register: bit.ly/3sRRkmU

Join is THIS Wed, Nov 29th at 6pm for another episode of our #LungCancer Webinar Series! Learn more about antibody drug conjugates from Dr. Aaron Lisberg <a href="/UCLAJCCC/">.</a> and <a href="/AMansfieldMD/">Aaron Mansfield</a> <a href="/MayoClinic/">Mayo Clinic</a>, moderated by <a href="/HatimHusainMD/">Hatim Husain</a> <a href="/UCSDCancer/">UC San Diego Health Moores Cancer Center</a>. Register: bit.ly/3sRRkmU
Charlie Rudin (@charlesrudin) 's Twitter Profile Photo

Are we heading toward a future where #lungcancer is NOT the leading cause of US cancer mortality in either men or women? Data out today in doi.org/10.3322/caac.2… continuing a nice trend --

Are we heading toward a future where #lungcancer is NOT the leading cause of US cancer mortality in either men or women? Data out today in doi.org/10.3322/caac.2… continuing a nice trend --
Targeted Oncology (@targetedonc) 's Twitter Profile Photo

Hatim Husain explained the significance of the PACIFIC trial and PACIFIC-R looking at the use of durvalumab after chemotherapy and radiation in patients with unresectable stage III #NSCLC. #lcsm targetedonc.com/view/husain-ev…

Hatim Husain (@hatimhusainmd) 's Twitter Profile Photo

So excited to meet and share insights on precision oncology and liquid biopsy strategies at the WIN Symposium 2024 in Abu Dhabi! #WINSYMPO2024 @winconsortium Burjeel Holdings

So excited to meet and share insights on precision oncology and liquid biopsy strategies at the WIN Symposium 2024 in Abu Dhabi! #WINSYMPO2024 @winconsortium <a href="/BurjeelHoldings/">Burjeel Holdings</a>
Targeted Oncology (@targetedonc) 's Twitter Profile Photo

WATCH: Hatim Husain provides an overview of adverse effects and management with KRAS targeted and immunotherapy combinations. #lcsm targetedonc.com/view/toxicity-…

Nature Portfolio (@natureportfolio) 's Twitter Profile Photo

Lung cancer in individuals who have never smoked (LCINS) is estimated to be the fifth most common cause of cancer-related deaths globally. A Review in NatureRevClinOncol reviews the emerging data regarding the causes and features of LCINS. 🔒 go.nature.com/3TcfOQO

Lung cancer in individuals who have never smoked (LCINS) is estimated to be the fifth most common cause of cancer-related deaths globally. A Review in <a href="/NatRevClinOncol/">NatureRevClinOncol</a> reviews the emerging data regarding the causes and features of LCINS. 🔒 go.nature.com/3TcfOQO
Christian Rolfo (@christianrolfo) 's Twitter Profile Photo

Thanks to ESMO - Eur. Oncology ESMO Daily for highlighting our paper in Clinical Cancer Research Tumor Fraction #liquidbiopsy. This is an important concept to distinguish non shedders to non informative LB. Lincoln Pasquina Hatim Husain The Tisch Cancer Institute Great comment by Umberto Malapelle dailyreporter.esmo.org/news/liquid-bi…

Thanks to <a href="/myESMO/">ESMO - Eur. Oncology</a> ESMO Daily for highlighting our paper in <a href="/CCR_AACR/">Clinical Cancer Research</a>  Tumor Fraction #liquidbiopsy. This is an important concept to distinguish non shedders to non informative LB.
<a href="/lpasquina/">Lincoln Pasquina</a> <a href="/HatimHusainMD/">Hatim Husain</a> 
<a href="/TischCancer/">The Tisch Cancer Institute</a> 
Great comment by <a href="/UmbertoMalapel1/">Umberto Malapelle</a>
dailyreporter.esmo.org/news/liquid-bi…
Kevin Lu (@thinkingcancer) 's Twitter Profile Photo

Wanted to express gratitude towards Hatim Husain for his sponsorship allowing me to share our work at #WCLC24 Little did I know I’d be presenting next to THE Heather Wakelee #lcsm #medtwitter

Wanted to express gratitude towards <a href="/HatimHusainMD/">Hatim Husain</a> for his sponsorship allowing me to share our work at #WCLC24 Little did I know I’d be presenting next to THE <a href="/HwakeleeMD/">Heather Wakelee</a> #lcsm #medtwitter
Matthew Lee (@matt_cw_lee) 's Twitter Profile Photo

Great talks last week at OncLive State of the Science Summit: Lung Cancer hosted by Jyoti Malhotra in ☀️Pasadena with talks by Hatim Husain on BRAF/KRAS and Jorge Nieva on ADCs snd Dr Antrim on EGFR and my presentation on updates on ALK+ field

Great talks last week at OncLive State of the Science Summit: Lung Cancer hosted by <a href="/JyotiMalhotraMD/">Jyoti Malhotra</a> in ☀️Pasadena with talks by <a href="/HatimHusainMD/">Hatim Husain</a> on BRAF/KRAS and <a href="/nievamd/">Jorge Nieva</a> on ADCs snd Dr Antrim on EGFR and my presentation on updates on ALK+ field